Around the Net
FDA Approves New Epilepsy Drug, Marketing Delayed
- MedPageToday.com, Tuesday, June 14, 2011 9:45 AM
The FDA has approved GlaxoSmithKline and Valeant Pharmaceuticals' new anti-epilepsy drug ezogabine (Potiga) as an add-on treatment for patients 18 and older with partial-onset seizures. But the FDA
committee overseeing approval also has concerns about the drug because 5% of patients experienced urinary dysfunction and retention. It will not be …
